Integrating Acupuncture Into the Management of Migraines

Migraine Headache Clinical Trial

Official title:

Integrating Acupuncture Into the Management of Migraines: A Randomized, Comparative Trial

Clinical Trial Details — Status: Terminated

Administrative data

• NCT number: NCT01481103
• Other study ID #: NUHS H1009
• Status: Terminated
• Phase: N/A
• First received: November 22, 2011
• Last updated: April 2, 2013
• Start date: July 2011
• Est. completion date: April 2013

Study information

• Verified date: April 2013
• Source: National University of Health Sciences
• Contact: n/a
• Is FDA regulated: No
• Health authority: United States: Institutional Review Board
• Study type: Interventional

Clinical Trial Summary

This research is being done to study the effect of incorporating acupuncture into the management of migraines. The primary aim is to determine in a randomized, controlled study whether individuals experiencing migraines have fewer occurrences and less intense migraines when acupuncture is integrated with nonprescription pharmacological treatment. Nonprescription pharmacological treatment in this study refers to the use of the following over the counter medications: Aspirin, Ibuprofen, Naproxen, Acetaminophen (with or without caffeine). Aspirin, Ibuprofen, and Naproxen are members of a class of drugs known as non-steroidal anti-inflammatory drugs or NSAIDs.

Description:

70 men and women between the ages of 18-65 diagnosed with migraines by a medical doctor. Participants must be using only nonprescription medication to treat their head pain.

Once initial eligibility has been determined and informed consent obtained, a Traditional Chinese Medicine (TCM) differential diagnosis will be carried out to determine the underlying cause of the migraines experienced by the participant. If the migraines are due to Liver Qi stagnation with Liver Yang rising they will be eligible for participation in the study. Eligible participants will be randomly assigned to one of two groups: Group 1 will continue taking their current nonprescription migraine medication as needed and will receive acupuncture once a week for 8 weeks. Group 2 will continue with their current nonprescription migraine medication as needed but will not receive acupuncture. The same set of predetermined acupuncture points will be used at each session.

All participants will complete a daily headache and medication use diary for four weeks on two separate occasions. In addition all participants will complete the Headache Impact Test (HIT-6) survey on three separate occasions.

Recruitment information / eligibility

• Status: Terminated
• Enrollment: 9
• Est. completion date: April 2013
• Est. primary completion date: April 2013
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 18 Years to 65 Years

Eligibility

Inclusion Criteria:

• Migraine with or without aura according to the International Headache Society classification and diagnosed by a Medical Doctor.

• Subjects are required to have between 2 and 12 migraines but no more than 15 headache days (migraine or nonmigraine) per 28 days during the prospective baseline phase. A headache day is defined as a calendar day during which the patient experienced headache for at least 30 minutes.

• Taking a nonprescription medication for the migraine pain. More specifically Aspirin, Ibuprofen, Naproxen, and/or Acetaminophen (with or without caffeine).

• Age between 18 and 65 years.

• A history of migraine for at least 12 months.

• Completed at least 75% of the baseline headache diary.

• Completion of written informed consent.

Exclusion Criteria:

• Onset of headache disorder less than 12 months prior to age 50.

• Pregnancy or planning to get pregnant while participating in the study.

• Malignancy; cluster headache (IHS code 3); sinus headaches.

• Suspicion that headache disorder has specific etiology (IHS code 5-11); cranial neuralgias (IHS code12)

• Acupuncture treatment in the previous 12 months.

• Taking a prescription medication for the migraine pain.

• Subject plans to receive acupuncture for another medical condition while participating in the study.

• Systemic disorder or illness, including serious psychiatric illness.

• Failure to fulfill baseline information.

• Failure to provide written informed consent.

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention

Related Conditions & MeSH terms

• Migraine Disorders
• Migraine Headache

Intervention

Procedure:
• Acupuncture
participants will receive 8 weekly acupuncture sessions. Acupuncture will be performed by a licensed acupuncturist. Each session will last approximately 25 minutes.

Locations

Country	Name	City	State
United States	Serenity Acupuncture and Oriental Medicine	Oak Park	Illinois

Sponsors (1)

Lead Sponsor	Collaborator
National University of Health Sciences

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Number and intensity of migraine headaches	Participants will be asked to maintain a daily diary of headache occurrences and medication use for 4 weeks prior to intervention and 4 weeks after intervention	16 weeks	No
Secondary	Medication consumed	Participants will be asked to maintain a daily diary of headache occurrences and medication use for 4 weeks prior to intervention and 4 weeks after intervention	16 weeks	No